Related Experiment Video
Updated: Aug 9, 2026
The In ovo CAM-assay as a Xenograft Model for Sarcoma
Published on: July 17, 2013
CaMKK2 as a therapeutic target to combat metastasis in glioblastoma
Geetha Sindogi1, Sandeep Mallya2, Manash K Paul3
1Department of Cellular and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.
Abstract:
Glioblastoma, an aggressive primary brain malignancy associated with poor survival rate and limited curative interventions, posing significant challenges in clinical management. Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) is known to regulate various cellular processes including energy homeostasis and immune modulation under normal physiological conditions as well as promoting metastasis in several cancer types. This review delves into the intricate involvement of CAMKK2 in the virulence of glioblastoma. Several studies have suggested that CAMKK2 can be a potential biomarker and therapeutic target for glioblastoma. Differential expression of CAMKK2 across glioma grades highlights its potential utility in disease stratification. Specifically, elevated CAMKK2 expression in high-grade gliomas is associated with increased metastatic potential. Furthermore, CAMKK2 ha been implicated in promoting resistance to immune checkpoint blockade therapy, underscoring its protumorigenic role. Given its involvement in tumor progression metastasis, modulation of the tumor microenvironment, and therapy resistance, CAMKK2 represents a promising candidate for the development of novel glioblastoma treatment strategies.
Insights
Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) drives glioblastoma virulence, metastasis, and therapy resistance. Targeting CAMKK2 offers a promising strategy for novel glioblastoma treatments.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Research
Background:
- Glioblastoma is an aggressive brain cancer with poor prognosis.
- CAMKK2 regulates cellular processes and cancer metastasis.
Purpose of the Study:
- To review the role of CAMKK2 in glioblastoma virulence.
- To explore CAMKK2 as a potential biomarker and therapeutic target.
Main Methods:
- Literature review of studies on CAMKK2 and glioblastoma.
- Analysis of CAMKK2 expression in different glioma grades.
Main Results:
- Elevated CAMKK2 expression correlates with high-grade gliomas and increased metastasis.
- CAMKK2 promotes resistance to immune checkpoint blockade therapy.
- CAMKK2 influences tumor microenvironment and progression.
Conclusions:
- CAMKK2 is implicated in glioblastoma progression, metastasis, and therapeutic resistance.
- CAMKK2 represents a promising therapeutic target for glioblastoma.
Related Concept Videos
02:15M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...